Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage

Slavianka G Moyanova1, Federica Mastroiacovo, Lidia V Kortenska

  • 1Department of Neurobiology of Processes of Adaptation, Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Insights

Activation of metabotropic glutamate 4 (mGlu4) receptors protects against ischemic brain damage. Enhancing mGlu4 receptors reduced infarct volume and improved functional recovery in rodent models of stroke.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Ischemic Stroke Research

Background:

  • Ischemic brain damage significantly contributes to neurological deficits.
  • Metabotropic glutamate 4 (mGlu4) receptors are implicated in neuronal function and survival.
  • Understanding the role of mGlu4 receptors in ischemia is crucial for developing neuroprotective strategies.

Purpose of the Study:

  • To investigate the neuroprotective effects of mGlu4 receptor activation in models of focal cerebral ischemia.
  • To evaluate the impact of mGlu4 receptor deficiency on ischemic brain injury.
  • To assess the therapeutic potential of selective mGlu4 receptor enhancers in stroke.

Main Methods:

  • Permanent middle cerebral artery occlusion (MCAO) model in mGlu4 receptor knockout and wild-type mice.
  • Endothelin-1 (Et-1) induced transient focal ischemia model in rats.
  • Administration of a selective mGlu4 receptor enhancer (PHCCC) before or after ischemic insult.
  • Assessment of infarct volume, neuronal function (electrocorticography), and sensorimotor deficits.

Main Results:

  • Mice lacking mGlu4 receptors exhibited a 25-30% increase in infarct volume after MCAO.
  • Systemic administration of PHCCC reduced ischemic brain damage by 35-45% in normal mice, but was ineffective in knockout mice.
  • PHCCC treatment post-ischemia reduced infarct volume in the caudate/putamen and cerebral cortex in the Et-1 model.
  • PHCCC-treated rats demonstrated faster recovery of neuronal function and improved sensorimotor performance.

Conclusions:

  • Activation of mGlu4 receptors confers significant neuroprotection against both permanent and transient focal cerebral ischemia.
  • Selective mGlu4 receptor enhancers, like PHCCC, show therapeutic promise for treating ischemic stroke.
  • These findings support the clinical development of mGlu4 receptor modulators for central nervous system disorders, including stroke and Parkinson's disease.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...